Anika Therapeutics | ANIK - Trade Creditors


Anika Therapeutics reported $6.04M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Abbott USD 4.12B 183M Sep/2025
Agenus USD 82.99M 2.3M Dec/2025
Agios Pharmaceuticals USD 18.36M 1.2M Dec/2025
Anika Therapeutics USD 6.04M 1.31M Dec/2025
Arrowhead Research USD 32.94M 15.26M Dec/2025
Enanta Pharmaceuticals USD 1.88M 63K Dec/2025
Halozyme Therapeutics USD 20.9M 5.54M Dec/2025
Heron Therapeutics USD 8.99M 3.02M Dec/2025
Insmed USD 79.91M 316K Dec/2025
Integra LifeSciences USD 95.73M 3.42M Dec/2025
Intrexon USD 4.85M 3.12M Jun/2024
J&J USD 11.99B 2.37B Dec/2025
Karyopharm Therapeutics USD 5.39M 2.8M Sep/2025
Ligand Pharmaceuticals USD 3.24M 24.52M Dec/2025
MacroGenics USD 4.79M 1.15M Dec/2025
Merit Medical Systems USD 60.55M 4.19M Dec/2025
Rigel Pharmaceuticals USD 3.85M 3.44M Sep/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sanofi EUR 22.93B 927M Dec/2025
Smith & Nephew USD 1.19B 73M Dec/2025
Stryker USD 1.5B 56M Sep/2025
Surmodics USD 2.79M 400K Sep/2024
Veracyte USD 4.59M 916K Dec/2025
Xencor USD 10.83M 1.75M Dec/2025
Zimmer Biomet Holdings USD 303M 12.3M Dec/2025